36 related articles for article (PubMed ID: 31970828)
21. Financial costs for families of children with Type 1 diabetes in lower-income countries.
Ogle GD; Kim H; Middlehurst AC; Silink M; Jenkins AJ
Diabet Med; 2016 Jun; 33(6):820-6. PubMed ID: 26482333
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
Siegel KR; Ali MK; Zhou X; Ng BP; Jawanda S; Proia K; Zhang X; Gregg EW; Albright AL; Zhang P
Diabetes Care; 2020 Jul; 43(7):1557-1592. PubMed ID: 33534729
[TBL] [Abstract][Full Text] [Related]
23. Psychological care in children and adolescents with type 1 diabetes in a real-world setting and associations with metabolic control.
Galler A; Hilgard D; Bollow E; Hermann T; Kretschmer N; Maier B; Mönkemöller K; Schiel R; Holl RW
Pediatr Diabetes; 2020 Sep; 21(6):1050-1058. PubMed ID: 32506592
[TBL] [Abstract][Full Text] [Related]
24. Excess mortality in Type 1 diabetes diagnosed in childhood and adolescence: a systematic review of population-based cohorts.
Morgan E; Cardwell CR; Black CJ; McCance DR; Patterson CC
Acta Diabetol; 2015 Aug; 52(4):801-7. PubMed ID: 25585594
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of type 1 diabetes.
Maahs DM; West NA; Lawrence JM; Mayer-Davis EJ
Endocrinol Metab Clin North Am; 2010 Sep; 39(3):481-97. PubMed ID: 20723815
[TBL] [Abstract][Full Text] [Related]
26. Costs and outcomes of "intermediate" vs "minimal" care for youth-onset type 1 diabetes in six countries.
Gregory GA; Guo J; Klatman EL; Ahmadov GA; Besançon S; Gomez ED; Fawwad A; Ramaiya K; Wijesuriya MA; Orchard TJ; Ogle GD
Pediatr Diabetes; 2020 Jun; 21(4):628-636. PubMed ID: 31970828
[TBL] [Abstract][Full Text] [Related]
27. Levels of type 1 diabetes care in children and adolescents for countries at varying resource levels.
Ogle GD; von Oettingen JE; Middlehurst AC; Hanas R; Orchard TJ
Pediatr Diabetes; 2019 Feb; 20(1):93-98. PubMed ID: 30471084
[TBL] [Abstract][Full Text] [Related]
28. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
29. The T1D Index: Implications of Initial Results, Data Limitations, and Future Development.
Ogle GD; Gregory GA; Wang F; Robinson TI; Maniam J; Magliano DJ; Orchard TJ
Curr Diab Rep; 2023 Oct; 23(10):277-291. PubMed ID: 37610700
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
